NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,269,000 | -16.9% | 120,670 | -0.8% | 0.07% | -24.1% |
| Q3 2021 | $13,553,000 | -7.3% | 121,615 | -5.5% | 0.09% | -8.4% |
| Q2 2021 | $14,614,000 | -15.3% | 128,723 | -24.2% | 0.10% | -21.5% |
| Q1 2021 | $17,244,000 | +3.7% | 169,828 | +1.7% | 0.12% | -21.4% |
| Q4 2020 | $16,627,000 | +40.7% | 167,067 | +2.1% | 0.15% | +2.7% |
| Q3 2020 | $11,818,000 | +46.7% | 163,589 | +1.3% | 0.15% | +41.5% |
| Q2 2020 | $8,055,000 | – | 161,552 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |